Medicine Pricing Policy in China

Slides:



Advertisements
Similar presentations
JFDA & HAI Workshop Towards equitable and affordable medicine prices policy in Jordan 4-5 December 2007 Strategies to aid market entry and competition.
Advertisements

Strategies to Improve Efficiency in Medicine Procurement Towards equitable and affordable medicine prices policies in Jordan Workshop 4-5 Dec, 2007 Dr.
Pharmaceutical Policy and Pricing: How are Countries Getting Greater Value? Commonwealth Fund/ Alliance for Health Reform Briefing on Capitol Hill Dr.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
Types of Economies Fill in the blanks on your worksheet
Importance of community-based services for persons with disabilities: Availability and quality International frame June 2012,Belgrade Dr.Vasilka.
Growing IKEA Together © Inter IKEA Systems B.V IKEA & Global Compliance Alex Chen & Alexandra Spiridoulias.
Transparency of China’s International Biddings of Electromechanical Products and the Complaints Handling Mechanism National Office for Import and Export.
I&EHL: EU Pharmaceutical Law André den Exter
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
The Korus FTA Will Lead to Higher Drug Prices in Korea
Healthcare Reform in China and Its Impact on the Pharmaceutical Industry Hengpeng Zhu Institute of Economics Chinese Academy of Social Sciences
AfDB - EBRD Joint conference in procurement reform in North Africa and SEMED Countries Marrakech 22 and 23 April 2013 Jordan Delegation 22-23/4/2013.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
Pricing and Reimbursement Policies 1. Pricing Policies Patented Medicines Maximum retail prices capped by Ministry of Economy (mainly for private sector)
Generic Substitution Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
National Medicine Policy
PREVENTIVE MEDICINE- PHC, NATIONAL TARGET PROGRAMS.
Karmen Hanson, MA Senior Policy Specialist National Conference of State Legislatures 340B Drug Purchasing: Options for States Overview of State Rx & 340B.
Tangible Construction Market and the On-line Monitoring System.
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
On ICH Feb. 13, 2013 Toshi Tominaga Ph. D. Food and Drug Evaluation Center, Osaka City Univ. Hospital International Regulatory Harmonization Amid Globalization.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
E P D K 1 Turkish Electricity Market and Recent Developments Cemal Çelik Energy Expert EMRA-TURKEY March ANTALYA.
ASSESSMENT OF AVAILABILITY, PRICE AND AFFORDABILITY OF MEDICINES FOR CHILDREN IN GHANA Authors: Gyansa-Lutterodt M. 1,Andrews Annan E. 2, Koduah A. 1,
VIETNAM’S DATA DISSEMINATION POLICY TRANG NGUYEN THU GENERAL STATISTICS OFFICE - VIETNAM GENERAL STATISTICS OFFICE - VIETNAM REGIONAL WORKSHOP ON DISSEMINATION.
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Margarit MELIKYAN Drug Utilization Research Group PO, Armenia, National Institute of Health Access to and Use of Medicines by Households in Armenia: Impact.
ACCESS TO MEDICINES - POLICY AND ISSUES
Pharmacists Perceptions of the Development of Herbal Medicines in Iran
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
System design for partial liberalization on electric industry Rules related to use of networks Establishment of a fair and transparent transmission rules.
1 Patient Safety In China Gao Xinqiang 23 June 2014.
HEALTH FINANCING MOH - HPG JAHR UPDATE ON POLICIES Eleventh Party Congress -Increase state investment while simultaneously mobilizing social mobilization.
Role Of ERC in the WESM To enforce the rules and regulations governing the operations of the WESM and monitors the activities of the Market Operator and.
Pharmaceutical Working Group Working Group on Pharmaceuticals Key Points for Advocacy and Action.
© OECD A joint initiative of the OECD and the European Union, principally financed by the EU Seminar on Green Public Procurement Bucharest, October.
Balancing Value and Access to Innovative Medicines The HSE Experience.
The First Conference for Medicines Regulatory Authorities In Sudan and Neighboring Countries Khartoum December 2014 Alain PRAT, Technical Officer,
Regulation of Generic Animal Drugs in the United States
State Regulation in the Natural Monopoly Sphere Agency of the Republic of Kazakhstan on Regulation of Natural Monopolies ALMATY – 2006.
Driver Education – Assessing What Works and What Doesn’t The Assessment Team Perspective AAMVA Region 1 Conference July 18, 2011 Baltimore, MD.
Economic Environment. Economic Factors Growth strategy Economic Systems Economic Planning Industry Agriculture Infrastructure Shumeet Grewal.
INTRODUCTION A national drug policy is a document which covers all the areas and issues related to drugs. This document outlines all aspects of drugs.
On the Legal System for the Right to Develop and Utilize Water Energy Resources in China Dr.Wang Mingyuan Professor and Director Center for Environmental,
Jordan Food & Drug Administration Administration.
Economics of Pharmaceutical Regulation in the Mediterranean: the case of Spain and Italy Joan Costa Font LSE.
China Health Technology Assessment (HTA) hub Prof
Pharmacy as a Business Explain third-party administration.
Clinical Research Contribution towards improving Clinical Care
Different World Economies
BASICS IN PHARMA.
Social Pharmacy and Pharmacoeconomics.
Community Participation in Research
Logez S, Hutin Y, Somda P, Thualt J, Holloway K
Industrial Pharmacy.
THE SELF MEDICATION MANUFACTURERS ASSOCIATION OF SOUTH AFRICA (SMASA)
Richard Laing EMP/WHO TBS 2012
Dr Samvel Azatyan Technical Officer Regulatory Support
The competition enforcement in regulated sectors
Health Technology Assessment
National Medicines Policies
Richard Laing WHO/PAU TBS 2013
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Prescription-only vs. over-the-counter medicines
MANPOWER PLANNING.
National Medicines Policies
Presentation transcript:

Medicine Pricing Policy in China Center for Medicine Price Setting National Development and Reform Committee, P.R. China Lu Fengxia Manila, Philippine 2-4 August 2006

Principles of the Policy 1、Offering good medical services with low cost 2、Government control combining with market mechanism

Foundation of the Policy 1、Drug Administration Law 2、Regulations for Implementation of the Drug Administration Law 3、Regulations on Medicine Price Setting by the Government 4、List for Medicines with price set by the Government

Scope of Medicines with Price set by the Government 1、Medicines on the Reimbursement List 2、Controlled medicines - Patented medicines - Narcotics - Psychological medicines - EPI vaccines

Medicine Pricing Forms Used by the Government Two forms: 1、Controlled medicines: - NDRC set factory price (or border price - Provincial price authorities set wholesale and retail price 2、Other medicines: - Setting maximum retail price

Jurisdiction of the Medicine Price Setting Two tiers: 1、Central price control authority 2、Provincial price authorities

Principles for Price Setting Basis Principles: ------Cost ------Supply and demand ------Affordability

Principles for Price Setting 1、Secure rational profit rate 2、Keep rational cost performance 3、Good quality with good price 4、Encourage R&D 5、Reflect market demand

Procedures for Medicine Price Setting 1、Cost assessment 2、Market price investigation 3、Regional coordination 4、Expert evaluation 5、Price publication

Medicine Price Setting Policy 1、Good quality with good price Quality, efficacy, safety and cost Quality examination Clinical validation Expert demonstration

Medicine Price Setting Policy 2、Differential Pricing Brand name medicines and generics Different dosages Different strengths Different packages

Medicine Price Setting Policy 3、Price for inviting bids Cost plus ratio for price of the bid winner Cost plus ratio is set by the provincial price authorities Price is checked by the party inviting tenders

Thanks!